Johnson & Johnson (JNJ)
160.29
-0.21
(-0.13%)
USD |
NYSE |
Oct 04, 16:00
160.25
-0.04
(-0.02%)
Pre-Market: 20:00
Johnson & Johnson Shareholders Equity (Annual): 68.77B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 68.77B |
December 31, 2022 | 76.80B |
December 31, 2021 | 74.02B |
December 31, 2020 | 63.28B |
December 31, 2019 | 59.47B |
December 31, 2018 | 59.75B |
December 31, 2017 | 60.16B |
December 31, 2016 | 70.42B |
December 31, 2015 | 71.15B |
December 31, 2014 | 69.75B |
December 31, 2013 | 74.05B |
December 31, 2012 | 64.83B |
December 31, 2011 | 57.08B |
December 31, 2010 | 56.58B |
December 31, 2009 | 50.59B |
December 31, 2008 | 42.51B |
December 31, 2007 | 43.32B |
December 31, 2006 | 39.32B |
December 31, 2005 | 38.71B |
December 31, 2004 | 31.81B |
Date | Value |
---|---|
December 31, 2003 | 26.87B |
December 31, 2002 | 22.70B |
December 31, 2001 | 24.23B |
December 31, 2000 | 20.40B |
December 31, 1999 | 16.21B |
December 31, 1998 | 14.08B |
December 31, 1997 | 12.36B |
December 31, 1996 | 10.84B |
December 31, 1995 | 9.045B |
December 31, 1994 | 7.122B |
December 31, 1993 | 5.568B |
December 31, 1992 | 5.171B |
December 31, 1991 | 5.626B |
December 31, 1990 | 4.90B |
December 31, 1989 | 4.148B |
December 31, 1988 | 3.503B |
December 31, 1987 | 3.485B |
December 31, 1986 | 2.824B |
December 31, 1985 | 3.351B |
December 31, 1984 | 2.932B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
59.47B
Minimum
2019
76.80B
Maximum
2022
68.47B
Average
68.77B
Median
2023
Shareholders Equity (Annual) Benchmarks
Amgen Inc | 6.232B |
Eli Lilly and Co | 10.77B |
Merck & Co Inc | 37.58B |
Pfizer Inc | 89.01B |
AbbVie Inc | 10.36B |